CHMP recommends for approval generic version of Prezista

At its November meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Prezista – Darunavir Mylan (darunavir) for the treatment of HIV infection.

Summary of opinion for Darunavir Mylan is available here.

Original Article